Dr. Shreshta Tripathi, a nephrology trainee from India, shares the story of a young girl living with Alport syndrome, an inherited kidney disorder that progressed to end-stage kidney disease at a young age. As dialysis, repeated infections, and financial hardship reshaped the family’s life, her parents faced the painful reality of being unable to donate a kidney themselves. After eventually receiving a transplant, the girl regained her strength and began rebuilding her future. Her journey highlights not only the medical burden of kidney disease, but also the emotional and economic impact it places on entire families. 

During my nephrology training, I learned to interpret numbers with precision: creatinine trends, potassium levels, dialysis adequacy, tacrolimus troughs {Editor’s note: Tacrolimus trough measure the lowest concentration of tacrolimus (an anti-rejection medication) in the bloodstream, just before the next scheduled dose}. But a young girl taught me that kidney disease is never merely numerical. 
 

This girl was diagnosed with Alport syndrome, an inherited disorder  passed silently through generations. In her case, that inheritance became the ultimate tragedy, a genetic script written long before she understood what illness meant, shaping not only her future but quietly reshaping her parents’ lives as well. 
 

By the time I met her, she was nearing end-stage kidney disease. She was young, filled with plans, still assembling her dreams. Yet instead of university forms and ambitions, she was learning about vascular access and transplant waiting lists. 
When transplantation was discussed, her parents immediately offered to donate. It was instinctive and unquestioned. Sadly, both were medically unfit. 

 
There is a particular silence that follows such news, a silence heavier than grief. In that room, I witnessed more than medicine. I saw the cruel irony of inheritance: a disease passed through blood, and yet blood could not redeem it. 
 

Dialysis began, imposing its rhythm upon her youth. Three sessions a week. Hours tethered to a machine. Fatigue that blurred concentration. Hospital corridors replacing classrooms. 
There were nights I was called to the dialysis unit for hypotension, alarms sounding, her blood pressure falling, her parents standing close but powerless. She developed repeated catheter-related bloodstream infections. Each episode brought Intensive Care Unit (ICU) admissions, strong antibiotics, invasive procedures, and financial strain. 

 
Every complication arrived in two forms: medical and economic. 

I often saw her parents outside the ICU, praying for stability while calculating expenses.

Their fear was layered. Not only “Will she survive?”,but also “Can we sustain this survival?”

In textbooks, Alport syndrome is described in genetic diagrams and basement membranes. In lived reality, it unfolds as disruption; of education, of savings, of certainty. An inherited mutation became an inherited burden, reshaping the destiny of an entire household. 
Eventually, a suitable donor was found, and she underwent transplantation. I remember the day she returned for follow-up. The pallor had lifted. Energy had returned. She spoke again of plans. 

 
She was no longer enduring life. She was inhabiting it. 
That is the triumph of transplantation: medicine’s quiet defiance of fate. 
Yet even in recovery, her parents would gently mention the loans taken, the savings exhausted, the assets sold. The disease had spared her life, but not the family’s stability. 
In countries like India, kidney failure is not only a medical diagnosis, it is also an economic reckoning. 

We speak globally of innovation and precision therapeutics. Yet for many families, the decisive variable is affordability. Science may advance, but access does not always follow at the same pace. 
This young girl survived because persistence aligned with opportunity. Many others are not granted that alignment. 
 

As I begin my career in public healthcare, I carry her story with me. She taught me that dialysis can eclipse adolescence, that infection is not merely a complication, but a compounding blow, and that transplantation restores not just physiology, but dignity. 
If we truly believe in Kidney Health for All, we must look beyond creatinine and confront the economic architecture that determines who receives timely care and who does not. 
 

Her graft function is stable today. 
But she altered my understanding of nephrology forever. 

She reminded me that behind every diagnosis is a family balancing hope, fear, guilt, biology, and economics, all at once. And that is where real kidney care begins.  

Disclaimer: The blog series is intended for informational purposes only and is not meant to endorse or promote any specific drug, product, or brand. Each individual’s experience is unique and should not be construed as medical advice or a guarantee of similar results for others. Always consult a qualified healthcare professional before making any decisions regarding your health and well-being.